Role Overview
We are seeking a Director, Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune to lead the development and execution of global market access strategies supporting early and late-stage development programs and future product launches across autoimmune diseases.
About Gilead sciences
Gilead and Kite are dedicated to curing cancer and developing groundbreaking treatments, including pioneering personalized CAR T-cell therapies that change medical paradigms.